NEUROG2 and glioblastoma: Among Neurog2-infected GBM cells, we detected a significant increase in the transcriptional activation of DCX (> 2,000-fold increase) at 7 dpi, which further surged to a 10,000-fold change at 14–21 dpi (Figure 1E; Neurog2).